Thursday, 3 November 2005 - 12:45 PM
489b
Breaking down Endolysosomal Barriers for Drug Delivery with Degradable Polymersomes
Fariyal Ahmed1, Goundla Srinivas
2, Aaron Brannan
3, Michael L. Klein
4, Frank S. Bates
3, and Dennis E. Discher
5. (1) Bioengineering, University of Pennsylvania, 220 South 33rd Street, Room 112 Towne Bldg., Philadelphia, PA 19104-6391, (2) Univ.Pennsylvania, Dept.Chemistry, Philadelphia, PA 19104, (3) Department of Chemical Engineering & Material Science, University of Minnesota, Minneapolis, MN 55455, (4) Chemistry, Univ.Pennsylvania, 112 Towne Bldg, Philadelphia, PA 19104, (5) Chemical & Biomolecular Engineering, University of Pennsylvania, 220 South 33rd Street, Room 112 Towne Bldg., Philadelphia, PA 19104-6391
Carrier-mediated entry of cytotoxic drugs into a cell's cytoplasm is often limited by release from the carrier as well as endosomal release after internalization. Here we demonstrate by molecular simulation and experiment that degradable, non-ionic polymersomes of PEG-(polyester) foster endosome rupture and release of cytotoxic drugs doxorubicin (DOX) and paclitaxel (TAX). These drugs are typical – soluble and insoluble – anticancer agents. We characterize the stability, delivery and intracellular toxicity of DOX- and TAX-loaded nano-polymersomes with breast and lung cancer cell lines that take up the vesicles. While degradable polymersome formulations retain their load for over a month at 4°C, they exhibit facilitated release at 37°C and low pH. Copolymer degradation fosters endosomal escape through copolymer-induced disruption of the lipid membrane, enhancing intracellular drug release and cytotoxicity up to 40-fold relative to free drug. More generally, the results show that macro-surfactants, which are increasingly being applied, will interact with cell membranes
See more of #489 - Bionanotechnology for Gene and Drug Delivery II (TH012)
See more of Topical H – Biomedical Applications of Nanotechnology (Bionanotechnology)
See more of The 2005 Annual Meeting (Cincinnati, OH)